海思科创新药环泊酚注射液获拓展儿童人群批准

Core Viewpoint - Company received approval from the National Medical Products Administration for a supplemental application regarding the use of Ropivacaine injection in children and adolescents for anesthesia induction and maintenance, along with revised safety information in the product instructions [1] Group 1 - Company subsidiary Shenyang Haishike Pharmaceutical Co., Ltd. has been granted a supplemental approval for Ropivacaine injection [1] - The approval includes specific usage guidelines for children and adolescents undergoing general anesthesia [1] - The product instructions have been updated to reflect new safety information [1]